Back

Risk-score performance for detecting transthyretin cardiac amyloidosis in severe aortic stenosis: a prospective cohort study

9 May 2026 (09:30 - 10:00)
Organised by: Logo
Congress Presentation Part of: Mechanisms and molecular insights in structural heart disease Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Katarzyna Graczyk

Jagiellonian University Medical College, John Paul II Hospital, Krakow (Poland)

4 More presentations in this session

Presentation thumbnail
Pre-intervention decompensation in severe aortic stenosis: the role of CT-derived extracellular volume
Doctor A. Lobo (Vila Nova de Gaia, PT)
Abstract Slides
Presentation thumbnail
Risk stratification after Takotsubo syndrome: long-term prognostic predictors
Doctor J. Fernandes Pedro (Lisbon, PT)
Abstract Slides
Presentation thumbnail
Heterogeneity of left ventricular remodelling patterns across severe aortic stenosis phenotypes
Doctor I. Rodrigues (Vila Nova de Gaia, PT)
Abstract Slides
Presentation thumbnail
Diastolic dysfunction in small and large animal models of moderate calcific aortic stenosis with preserved ejection fraction is heart rate dependent
Doctor G. Geist (South San Francisco, US)
Abstract Slides

Access the full session

Session thumbnail
Mechanisms and molecular insights in structural heart disease

The Event

Event poster

Heart Failure 2026

9 May 2026 09:30 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources